4FOX Ventures
Switzerland
- Lausanne
- 17/11/2022
- Series A
- $5,000,000
4FOX Ventures is a leading Swiss healthcare and technology focused venture capital team managing a portfolio of over 10 highly innovative and fast-growing companies composed, amongst others, of:
(i) Ecorobotix (https://www.ecorobotix.com/en/);
(ii) Neomedical (https://neo-medical.com/);
(iii) Giotto Compliance (https://giotto.ai/);
(iv) Aspivix (https://www.aspivix.com/);
(v) Artiria Medical (https://artiria-medical.com/);
(vi) Positrigo (https://www.positrigo.com/);
(vii) Vima (https://vima-swiss.com/);
(viii) Faveeo (https://www.faveeo.com/);
(ix) Kairos (https://www.kairosfire.com/);
(x) Scailyte (https://scailyte.com/).
We usually invest as first institutional investor in early stage Swiss companies with potential to develop and tackle early on the booming Asian market.
Through active board representation, we deliver direct operational and industry support.
- Industry Venture Capital and Private Equity Principals
- Website http://4fox-ventures.com/
- LinkedIn https://www.linkedin.com/company/4fox-ventures/
Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Lucis (YC X25) | $8,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)